Table 2

Characteristics of included studies regarding the second study aim: determinants of revisits

Author
Year
Country
Study designArticle/abstractDisease/working diagnosisPrimary outcome: revisitsN total, male % of total populationN outcome (revisits), male %Age inclusion
Median (IQR)/mean age (SD)
Follow-up* (days)Type of revisitRisk of bias† (high/low)
Alessandrini 2004 USACRArticleAllYes54 784
NR
1893
NR
All
4.6 years ±4.9‡
2suRLow
Ali 2012 USACPArticleAllYes8742
NR
124
52%
All
3.0 years (1.1–12)‡
3suRHigh
Angoulvant 2012 FranceCPArticleAll§Yes501
NR
206
51%
<6 years
18 months (7–39)
7suRHigh
Augustine 2013 USACSAbstractAllYes13
NR
13
NR
All
4.2 years¶
2uRHigh
Berry 2013 USACRArticleAllYes568 845
NR
36 734**
NR
≤18 years
3 years (0–10)
30uRLow
Black 2010 UKCRAbstractAllYes2345
NR
91
NR
<17 years
76% <5 years
3uRHigh
Callery 2010 UKCRArticleAllYes43 372
NR
2433
NR
<15 years
NR
7suRLow
Chang 2008 TaiwanCRArticleAllNo3216
58%
188
NR
<18 years
5 years ±0.1
3suRLow
DePiero 2002 USACRArticleAllYes51 195
NR
261**
NR
All
NR
3suRLow
Dunlop 2005 AustraliaCRArticleFeverNo260 52%35 NR6 months to 6 years
25.7 months††
1suRHigh
Easter 2012 USACRArticleAllYes97 374
NR
1091**
52%
0–21 years
52% <5 years‡
4suRLow
Florin 2013 USACRArticlePneumoniaYes100 615
54%
6439
NR
2 months to 18 years
3 years (1–6)
3suRLow
Freedman 2013 CanadaCRArticleGEYes3346
55%
526
57%
<18 years
3.4 years ±3.5
7uRLow
Gallagher 2013 USACRArticleAllYes119 792
53%
1499**
NR
All
7.6 years¶
3uRLow
Gaucher 2012 CanadaCRArticleAllNo49 146
51%
2534
NR
<19 years
62% <5 years
2uRLow
Goldman 2006 CanadaCRArticleAllYes37 725
NR
1990
NR
<19 years
18% <1 year
3uRLow
Goldman 2011 CanadaCRArticleAllYes2062
55%
353**
59%
<19 years
57 months (0–215)
3suRHigh
Gregor 2009 USACPArticleRTI/GENo455
59%
49
NR
6 weeks to 8 years
1.9 years ±1.9
60suRHigh
Hacking 2012 UKCRAbstractAllYes2453
NR
130
NR
NR
4 years††
NRuRHigh
Jacobstein 2005 USACCArticleFeverYes15 384
54%
165
54%
All
38 months ±43
3uRLow
Jain 2010 USACRArticleAllNo452 868
54%
17 335
NR
<19 years
22% <1 years
3suRLow
Klein-Kremer 2011 CanadaCRArticleFeverYes397
NR
92
67%
3–36 months
17 months ±8‡
3suRHigh
Lal et al 1999 UKCPArticleAllYes7328
NR
65
NR
NR3uRHigh
LeDuc 2006 USACPArticleAllYes932
NR
237
49%
All
4 years¶
2, 90suRHigh
Liberman 2012 USACRArticleRTINo467
59%
189
NR
<19 years
NR
7, 30suRLow
Logue 2013 CanadaCRArticleAllYes1173
NR
261
61%
All
4.4 years¶
3suRHigh
Maguire‡‡ 2011 UKCPArticleFeverNo220
56%
127
NR
<5 years
27% ≤1 years
NSsuRHigh
Mansbach 2008 USACPArticleBronchiolitisNo1456
58%
837
58%
<2 years
6.9 (4.2–11.3)§§
14NSLow
Michelson 2012 USACRArticleAllNo198 778
NR
7281
NR
All
10% <1 years
2suRHigh
Mintegui 2000 SpainCRAbstractAllYes3667 NR495 NRAll NR7uRHigh
Mistry 2007 USACPArticleFeverYes322
57%
76
NR
28 days to 17 years
31.5 months¶
10uRHigh
Mistry 2009 USACPArticleFeverNo97
56%
18
NR
2–18 years
58.7 months ±40.1
7–10uRHigh
Moineau‡‡ 2004 CanadaCRAbstractGEYes1862
NR
108
NR
NR
2.6 years ±2.8
7uRHigh
O'Loughlin 2012 UKCRArticleAllYes10 573
NR
532
NR
<16 years
34% <2 years
7uRHigh
Roback 1997 USACCArticleBronchiolitisYes181
NR
57
NR
<1 year
NR
4NSHigh
Roggen 2012 BelgiumCRAbstractAll§Yes46 386
NR
1864
NR
<16 years
NR
3suRHigh
Samuels-Kalow 2013 CanadaCRAbstractFeverYes202
NR
14
NR
2–24 months
NR
3suRHigh
Sartain 2002 UKRCTArticleAllNo39931
NS
All
25.7 months¶
90suRHigh
Seow 2007 TaiwanCRArticleFeverNo345
47%
115
NR
3–36 months
NR
3uRLow
Simmons 2012 UKCRAbstractAllYesNR51
NR
All
59% <2 years
7uRHigh
Small 2005 UKCPArticleGENo112
NR
56
NR
1–6 years
1.9 (1.3)**
7, 30suRLow
Zimmerman 1996 USACRArticleAllYes5228
58%
242
NR
<18 years
13% <1 years
14suRLow
  • *Time until revisit.

  • †Minimum and maximum.

  • ‡Of the number of children with revisits.

  • §Common illnesses, without children with traumatic complaints.

  • ¶Mean (CI).

  • **Revisits requiring admission.

  • ††Median (IQR).

  • ‡‡Studies included for both study aims (Maguire et al12 and Moineau et al13).

  • §§Of the number of children sent home.

  • All, all emergency department diagnoses; CC, case–control study; CP, cohort study, prospective; CR, cohort study, retrospective; CS, cross-sectional study; GE, gastroenteritis; NR, not recorded; RCT, randomised controlled trial; RTI, respiratory tract illnesses; suR, scheduled and unscheduled revisit; uR, unscheduled revisit.